MedAvail Holdings, Inc.
MDVLDelisted Mar 21, 2024- Industry
- Retail-Drug Stores and Proprietary Stores
- SEC CIK
- 0001402479
MedAvail Holdings, Inc. was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Feb 6, 2024; 21 institutions reported holding it in 13F filings for Q4 2023, worth $6.16M in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in MedAvail Holdings, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- 0 vs. Q1 2023
- Shares held
- 67.5M
- −720.0K (−1.1%) vs. Q1 2023
- Total value
- $16.5M
- −$3.00M (−15.4%) vs. Q1 2023
- New holders
- 2
- 2 more added
- Sold out
- 2
- 5 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MDVL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 21 | $6.16M |
| Q3 2023 | 19 | $8.08M |
| Q2 2023 | 27 | $16.5M |
| Q1 2023 | 27 | $19.5M |
| Q4 2022 | 32 | $20.6M |
| Q3 2022 | 33 | $53.9M |
| Q2 2022 | 40 | $92.8M |
| Q1 2022 | 50 | $30.0M |
| Q4 2021 | 53 | $36.8M |
| Q3 2021 | 49 | $78.5M |
| Q2 2021 | 45 | $348.1M |
| Q1 2021 | 34 | $372.4M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding MedAvail Holdings, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 893 | $0 | 0.00% | +893 | New |
| Global Retirement Partners, LLC | 430 | $105 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 3,000 | $736 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 4,949 | $1.21K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 6,110 | $1.50K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 11,882 | $2.91K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 13,184 | $3.23K | 0.00% | 00.0% | Unchanged |
| BBR Partners, LLC | 15,237 | $3.73K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 15,732 | $3.86K | 0.00% | −139,818−89.9% | Reduced |
| Joel Isaacson & Co., LLC | 18,741 | $4.59K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 21,496 | $5.27K | 0.00% | +20,008+1,344.6% | Added |
| Tower Research Capital LLC (TRC) | 34,311 | $8.41K | 0.00% | +17,344+102.2% | Added |
| State Street Corp | 41,258 | $10.1K | 0.00% | −2,100−4.8% | Reduced |
| Northern Trust Corp | 42,712 | $10.5K | 0.00% | 00.0% | Unchanged |
| Pura Vida Investments, LLC | 58,070 | $18.8K | 0.01% | −273,691−82.5% | Reduced |
| Renaissance Technologies LLC | 79,500 | $19.0K | 0.00% | +79,500 | New |
| BlackRock Inc. | 101,822 | $25.0K | 0.00% | −68,058−40.1% | Reduced |
| Geode Capital Management, LLC | 183,909 | $45.1K | 0.00% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 836,626 | $205.1K | 0.00% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,000,000 | $245.1K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,058,476 | $259.4K | 0.00% | 00.0% | Unchanged |
| Cigna Investments Inc | 2,389,478 | $586.0K | 0.11% | 00.0% | Unchanged |
| Ally Bridge Group (NY) LLC | 5,894,897 | $1.44M | 1.75% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 6,015,043 | $1.47M | 0.01% | −324,051−5.1% | Reduced |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 15,029,480 | $3.68M | 66.84% | 00.0% | Unchanged |
| Redmile Group, LLC | 34,604,516 | $8.48M | 0.33% | 00.0% | Unchanged |
| Condor Capital Management | 0 | $0 | 0.00% | −17,838−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −12,151−100.0% | Sold out |